Harnessing the pipeline: partnering with big medtech
Wednesday 22 May | 10:55am - 11:55am
Across the ecosystem for medtech companies commercialising biomedical research, there is an interdependent relationship between small and large companies. Multinational companies are a critical part of the Australian landscape, with their ability to provide the resources, experience, and infrastructure necessary to support R&D, clinical development, manufacturing, and distribution of devices and diagnostics.
This plenary session provides an invaluable opportunity to hear from big medtech on partnering, prospecting and support work in the Australian environment.
Chair:
Dell Kingsford Smith, AusBiotech Board; Vice President Medical Affairs, Market Access & Government Affairs, Asia Pacific, Cochlear
Panellists:
- Maurice Ben-Mayor, President & Managing Director, Stryker
- Mick Trevaskis, Chief Executive Officer, Device Technologies
- Rebecca Cortiula, Senior Managing Director Australasia, Varian
- Jane Crowe, Managing Director, ANZ Cardinal Health
- Pat Williams, Vice President & Country Manager ANZ & Korea, Edwards Lifesciences
AusMedtech 2024 Conference Dinner
Wednesday 22 May | 7:30pm - 10:00pm
Tickets required. The Conference Dinner is the social highlight of AusMedtech, providing an evening of networking opportunities for guests.
With Australia’s indigenous communities overrepresented in low socioeconomic figures, Australia’s First Nations people face a greater risk of poor health, higher rates of illness, disability, and death, and live shorter lives than people from higher socioeconomic groups.
Founded in the Northern Territory, not-for-profit Red Dust draws on the strengths of both western health knowledge and traditional cultural knowledges to create a positive influence on young people and improve outcomes for communities. Providing a ‘community-as-family’ model of health and well-being programmes, Red Dust works alongside community leaders and elders to create a stronger future for indigenous youth and their families.
Join us for a fireside chat with Red Dust, Director of Programs and Strategy Lead Jonathan Hermawan and CEO Scott Stirling, as they discuss their personal journey over the past seven years growing Red Dust and developing a cooperative model that is charting a new course and leading to improved health and wellbeing outcomes.
Dinner speakers:
Scott Stirling, Chief Executive Officer
Jonathon Lindsay-Tjapaltjarri, Hermawan, Director of Programs and Strategy Lead, Red Dust
Facilitator: Rebekah Cassidy, Chief Executive Officer, AusBiotech
Early-Stage Innovation Forum
Wednesday 22 May | 1:55pm - 5:10pm
A key element of AusMedtech 2024 is the Early-Stage Innovation Forum, featuring rapid fire rounds of quick-pitch presentations on early-stage technologies and projects from local research institutes, universities, hospitals and pre-series A companies in the areas of medical devices and diagnostics, digital health and enabling technologies.
See here for more information.
